MADELEINE GARAICOA: Open Payments
NPI 1194287821 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 17 payments from 11 companies in 2025. Trend: 2023 $87 · 2024 $539 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $252 |
| Madrigal Pharmaceuticals | 1 | $144 |
| Ardelyx, Inc. | 4 | $100 |
| Insmed, Inc. | 2 | $67 |
| ABBVIE INC. | 2 | $53 |
| Exact Sciences Corporation | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $26 |
| Fresenius USA Manufacturing, Inc. | 1 | $24 |
Products named: REZDIFFRA, XIFAXAN, TRULANCE, IBSRELA, Arikayce, MAVYRET, Cologuard Collection Kit, VELSIPITY.
Industry payments across NY — which companies pay providers there.
